Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
624.00    -3.00 (-0.48%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £543.66m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Management Change

27 Apr 2012 07:00

RNS Number : 1795C
Victrex PLC
27 April 2012
 



27 April 2012

 

Victrex plc

 

Management Change

 

Victrex plc ("the Company") today announces that Hichem M'Saad has been appointed as Managing Director of our Invibio® Biomaterial Solutions business unit ("Invibio"). Hichem will join the Company on 18 June 2012, succeeding Michael Callahan, who will remain on the Invibio board as leader of the spine business.

 

Prior to joining Invibio Hichem's career included 14 years at Applied Materials Inc, most recently as Corporate Vice President and General Manager of their Silicon Sector Group. Hichem holds a PhD in Materials Science and Engineering from the Massachusetts Institute of Technology and has extensive commercial and technical experience globally, in both start-up and mature businesses.

David Hummel, Chief Executive said:

 

"I am delighted that Hichem is joining Invibio. His wealth of general management and commercial experience in technology driven businesses will enable him to lead Invibio into a new phase of growth and realise opportunities in new and existing market areas. He will be a valuable asset to both Invibio and the wider Victrex Group.

 

I would like to thank Michael for his contribution to the Invibio business since its launch in 2001. Michael has supported us through a period of significant growth, development and investment, and will continue to deliver Invibio's strategy in the spine business going forward."

 

 

Enquiries

 

Victrex plc

01253 898067

David Hummel, Chief Executive

Steve Barrow, Finance Director

MHP Communications

Nick Denton / Barnaby Fry / Ian Payne

0203 128 8100

 

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a provider of innovative, high performance thermoplastic polymers. We work with customers and end users globally to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions business unit ('VPS') focuses on our transport, industrial and electronics markets and our Invibio® Biomaterial Solutions business unit ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUGPCUPPGAQ
Date   Source Headline
10th May 20231:34 pmRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSVictrex plc - Interim Results 2023
28th Apr 20239:33 amRNSTotal Voting Rights
18th Apr 20232:00 pmRNSHolding(s) in Company
18th Apr 202310:50 amRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSDirectorate Change
31st Mar 202310:52 amRNSTotal Voting Rights
20th Mar 20233:07 pmRNSHolding(s) in Company
20th Mar 202310:15 amRNSDirector/PDMR Shareholding
13th Mar 202310:14 amRNSAdditional Listing
28th Feb 20239:35 amRNSTotal Voting Rights
17th Feb 202310:06 amRNSDirector/PDMR Shareholding
14th Feb 202312:20 pmRNSDirector/PDMR Shareholding
10th Feb 20232:12 pmRNSDirector/PDMR Shareholding
10th Feb 202312:29 pmRNSResult of AGM
10th Feb 20237:00 amRNSAGM & Q1 Interim Management Statement
31st Jan 202310:43 amRNSTotal Voting Rights
17th Jan 20232:12 pmRNSDirector/PDMR Shareholding
12th Jan 20232:28 pmRNSCorrection - AGM Resolution Proposal
6th Jan 20232:58 pmRNSAnnual Report and Accounts
30th Dec 20229:00 amRNSTotal Voting Rights
22nd Dec 202211:30 amRNSDirector/PDMR Shareholding
19th Dec 202212:04 pmRNSDirector/PDMR Shareholding
19th Dec 202210:56 amRNSDirector/PDMR Shareholding
13th Dec 202211:16 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSVictrex plc – Preliminary Results 2022
1st Dec 202211:49 amRNSBlock listing Interim Review
30th Nov 20229:27 amRNSTotal Voting Rights
29th Nov 20224:05 pmRNSHolding(s) in Company
17th Nov 20222:50 pmRNSDirector/PDMR Shareholding
17th Nov 20221:35 pmRNSAdditional Listing
31st Oct 202212:55 pmRNSTotal Voting Rights
18th Oct 202212:26 pmRNSDirector/PDMR Shareholding
30th Sep 202211:03 amRNSTotal Voting Rights
28th Sep 20229:44 amRNSHolding(s) in Company
20th Sep 20224:05 pmRNSDirector/PDMR Shareholding
31st Aug 20229:00 amRNSTotal Voting Rights
17th Aug 20222:31 pmRNSDirector/PDMR Shareholding
29th Jul 202210:01 amRNSTotal Voting Rights
19th Jul 20222:41 pmRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSVictrex Q3 Interim Management Statement
30th Jun 202210:28 amRNSTotal Voting Rights
21st Jun 202212:41 pmRNSDirector/PDMR Shareholding
7th Jun 202211:45 amRNSBlock listing Interim Review
31st May 20229:59 amRNSTotal Voting Rights
27th May 20229:40 amRNSHolding(s) in Company
17th May 20223:58 pmRNSHolding(s) in Company
17th May 202212:19 pmRNSDirector/PDMR Shareholding
13th May 202211:02 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSVictrex plc – Interim Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.